Nobel Laureate David Baltimore reviews NF-κB research: Mastering cell fate, regulating health and disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Oct-2025 16:11 ET (3-Oct-2025 20:11 GMT/UTC)
Professor Alexander Hoffmann and Genhong Cheng from University of California, Los Angeles, jointly with Professor David Baltimore from California Institute of Technology, published a review article in the newly launched journal Immunity & Inflammation. This article provides a systematic overview of NF-κB, covering its activation mechanisms, gene regulatory networks, physiological and pathological roles. It also summarizes recent advances in therapeutic strategies targeting NF-κB, offering a critical foundation for deeper understanding the pathway’s functions and mechanisms.
The unfolded protein response (UPR) is a protective pathway that helps cells manage stress during protein production. Cancer cells exploit this system to survive harsh tumor environments. In bones, they also disrupt the balance of bone-building and bone-resorbing cells, leading to skeletal fragility. Emerging therapies that target the UPR show promise in restoring bone health while selectively killing malignant cells, offering new hope for patients with cancer-associated bone disease.
A Science China Life Sciences study reveals that glioblastoma (GBM) hijacks oxygen-deprived conditions by forming nuclear “stress droplets” that activate the enzyme PRMT2, fueling tumor survival independently of the classic HIF pathway. Blocking PRMT2’s phosphorylation with the orphan drug TG02 dismantles these droplets and—when combined with standard chemotherapy temozolomide—restores drug sensitivity, dramatically shrinking tumors and extending survival in resistant mouse models.
A large-scale metagenomic study of 2,561 gut samples from 14 mammal species on the Tibetan Plateau reconstructed 112,313 metagenome-assembled genomes representing 21,902 microbial species (86% unclassified) and identified 8,598 nonredundant antibiotic resistance genes (ARGs) spanning 28 types. The authors report 334 high-risk ARGs and seven cross-species horizontal gene transfer events involving high-risk ARGs, including three transfers between humans and nonhuman mammals. Additionally, the abundance of ARGs in human gut microbiomes on the Tibetan Plateau was greater than that in those from eastern China, Europe, and the United States, whereas the abundance of ARGs in livestock gut microbiomes from the Tibetan Plateau was lower than that in livestock gut microbiomes from those regions. This study reveals that the gut microbiota of Tibetan Plateau mammals is a largely unexplored resource and a significant reservoir of ARGs, offering crucial insights into microbiome research and demonstrating potential public health implications.